Israeli company Intec Pharma has announced that following the successful phase II clinical trial for its accordion capsule, the capsule and procedure will receive a US patent. The accordion capsule is designed to treat advanced Parkinson’s disease.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments